Working… Menu

Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03438318
Recruitment Status : Completed
First Posted : February 19, 2018
Last Update Posted : May 15, 2020
Novella Clinical
Information provided by (Responsible Party):
Checkmate Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 11, 2019
Actual Study Completion Date : December 11, 2019